345 related articles for article (PubMed ID: 25396298)
21. The roles of ebolavirus glycoproteins in viral pathogenesis.
Ning YJ; Deng F; Hu Z; Wang H
Virol Sin; 2017 Feb; 32(1):3-15. PubMed ID: 27853993
[TBL] [Abstract][Full Text] [Related]
22. The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.
Dilley KA; Voorhies AA; Luthra P; Puri V; Stockwell TB; Lorenzi H; Basler CF; Shabman RS
PLoS One; 2017; 12(6):e0178717. PubMed ID: 28636653
[TBL] [Abstract][Full Text] [Related]
23. A Luciferase Reporter Gene Assay to Measure Ebola Virus Viral Protein 35-Associated Inhibition of Double-Stranded RNA-Stimulated, Retinoic Acid-Inducible Gene 1-Mediated Induction of Interferon β.
Cannas V; Daino GL; Corona A; Esposito F; Tramontano E
J Infect Dis; 2015 Oct; 212 Suppl 2():S277-81. PubMed ID: 25926684
[TBL] [Abstract][Full Text] [Related]
24. Entry of Ebola Virus is an Asynchronous Process.
Reynard O; Volchkov VE
J Infect Dis; 2015 Oct; 212 Suppl 2():S199-203. PubMed ID: 25941332
[TBL] [Abstract][Full Text] [Related]
25. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
[TBL] [Abstract][Full Text] [Related]
26. Evaluation in nonhuman primates of vaccines against Ebola virus.
Geisbert TW; Pushko P; Anderson K; Smith J; Davis KJ; Jahrling PB
Emerg Infect Dis; 2002 May; 8(5):503-7. PubMed ID: 11996686
[TBL] [Abstract][Full Text] [Related]
27. mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms.
Qiu X; Wong G; Fernando L; Audet J; Bello A; Strong J; Alimonti JB; Kobinger GP
Sci Transl Med; 2013 Oct; 5(207):207ra143. PubMed ID: 24132638
[TBL] [Abstract][Full Text] [Related]
28. Ebola Immunity: Gaining a Winning Position in Lightning Chess.
Ploquin A; Zhou Y; Sullivan NJ
J Immunol; 2018 Aug; 201(3):833-842. PubMed ID: 30038036
[TBL] [Abstract][Full Text] [Related]
29. Different effects of two mutations on the infectivity of Ebola virus glycoprotein in nine mammalian species.
Kurosaki Y; Ueda MT; Nakano Y; Yasuda J; Koyanagi Y; Sato K; Nakagawa S
J Gen Virol; 2018 Feb; 99(2):181-186. PubMed ID: 29300152
[TBL] [Abstract][Full Text] [Related]
30. Characterization of host immune responses in Ebola virus infections.
Wong G; Kobinger GP; Qiu X
Expert Rev Clin Immunol; 2014 Jun; 10(6):781-90. PubMed ID: 24742338
[TBL] [Abstract][Full Text] [Related]
31. The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis.
Feldmann H; Volchkov VE; Volchkova VA; Klenk HD
Arch Virol Suppl; 1999; 15():159-69. PubMed ID: 10470276
[TBL] [Abstract][Full Text] [Related]
32. Optimization of Prime-Boost Vaccination Strategies Against Mouse-Adapted Ebolavirus in a Short-Term Protection Study.
Aviles J; Bello A; Wong G; Fausther-Bovendo H; Qiu X; Kobinger G
J Infect Dis; 2015 Oct; 212 Suppl 2():S389-97. PubMed ID: 26038398
[TBL] [Abstract][Full Text] [Related]
33. A single phosphorodiamidate morpholino oligomer targeting VP24 protects rhesus monkeys against lethal Ebola virus infection.
Warren TK; Whitehouse CA; Wells J; Welch L; Heald AE; Charleston JS; Sazani P; Reid SP; Iversen PL; Bavari S
mBio; 2015 Feb; 6(1):. PubMed ID: 25670780
[TBL] [Abstract][Full Text] [Related]
34. Ebola virus replication is regulated by the phosphorylation of viral protein VP35.
Zhu L; Gao T; Yang W; Liu Y; Liu X; Hu Y; Jin Y; Li P; Xu K; Zou G; Zhao L; Cao R; Zhong W; Xia X; Cao C
Biochem Biophys Res Commun; 2020 Jan; 521(3):687-692. PubMed ID: 31694758
[TBL] [Abstract][Full Text] [Related]
35. Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion.
Pleet ML; DeMarino C; Stonier SW; Dye JM; Jacobson S; Aman MJ; Kashanchi F
Viruses; 2019 May; 11(5):. PubMed ID: 31052499
[TBL] [Abstract][Full Text] [Related]
36. Structures of Ebola virus GP and sGP in complex with therapeutic antibodies.
Pallesen J; Murin CD; de Val N; Cottrell CA; Hastie KM; Turner HL; Fusco ML; Flyak AI; Zeitlin L; Crowe JE; Andersen KG; Saphire EO; Ward AB
Nat Microbiol; 2016 Aug; 1(9):16128. PubMed ID: 27562261
[TBL] [Abstract][Full Text] [Related]
37. Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.
Warfield KL; Swenson DL; Olinger GG; Kalina WV; Aman MJ; Bavari S
J Infect Dis; 2007 Nov; 196 Suppl 2():S430-7. PubMed ID: 17940980
[TBL] [Abstract][Full Text] [Related]
38. Cynarin blocks Ebola virus replication by counteracting VP35 inhibition of interferon-beta production.
Corona A; Fanunza E; Salata C; Morwitzer MJ; Distinto S; Zinzula L; Sanna C; Frau A; Daino GL; Quartu M; Taglialatela-Scafati O; Rigano D; Reid S; Mirazimi A; Tramontano E
Antiviral Res; 2022 Feb; 198():105251. PubMed ID: 35066016
[TBL] [Abstract][Full Text] [Related]
39. Ebolavirus Species-Specific Interferon Antagonism Mediated by VP24.
Ramanathan P; Tigabu B; Santos RI; Ilinykh PA; Kuzmina N; Vogel OA; Thakur N; Ahmed H; Wu C; Amarasinghe GK; Basler CF; Bukreyev A
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243162
[TBL] [Abstract][Full Text] [Related]
40. Elucidation of the Ebola virus VP24 cellular interactome and disruption of virus biology through targeted inhibition of host-cell protein function.
García-Dorival I; Wu W; Dowall S; Armstrong S; Touzelet O; Wastling J; Barr JN; Matthews D; Carroll M; Hewson R; Hiscox JA
J Proteome Res; 2014 Nov; 13(11):5120-35. PubMed ID: 25158218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
